Tomas Navratil
Corporate Officer/Principal en GLAUKOS CORPORATION .
Fortuna: 2 M $ al 31/03/2024
Perfil
Tomas Navratil is currently the Chief Development Officer at Glaukos Corp.
He also holds a position on the Member-Supervisory Board at Severomoravske Vodovody a Kanalizace Ostrava as.
Previously, he worked as the Director-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc., the Executive Director-Clinical Research at Parion Sciences, Inc., the General Manager at Nicox Ophthalmics, Inc., the Executive VP, Global Head-Research & Development at Nicox SA, and the Senior Vice President-Development at Envisia Therapeutics, Inc. Dr. Navratil obtained his undergraduate and doctorate degrees from The University of North Carolina at Charlotte.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
GLAUKOS CORP
0.05% | 05/04/2024 | 25 075 ( 0.05% ) | 2 M $ | 31/03/2024 |
Cargos activos de Tomas Navratil
Empresas | Cargo | Inicio |
---|---|---|
GLAUKOS CORPORATION | Corporate Officer/Principal | 01/04/2022 |
Severomoravske Vodovody a Kanalizace Ostrava as
Severomoravske Vodovody a Kanalizace Ostrava as Water UtilitiesUtilities Severomoravske Vodovody a Kanalizace Ostrava AS engages in the production and supply of drinking water. It also deals with the discharge and treatment of wastewater. The company was founded on April 30, 1992 and is headquartered in Ostrava, Czech Republic. | Director/Board Member | - |
Antiguos cargos conocidos de Tomas Navratil.
Empresas | Cargo | Fin |
---|---|---|
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Chief Tech/Sci/R&D Officer | - |
NICOX SA | Chief Tech/Sci/R&D Officer | - |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Formación de Tomas Navratil.
The University of North Carolina at Charlotte | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GLAUKOS CORPORATION | Health Technology |
NICOX SA | Health Technology |
Empresas privadas | 5 |
---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Commercial Services |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Severomoravske Vodovody a Kanalizace Ostrava as
Severomoravske Vodovody a Kanalizace Ostrava as Water UtilitiesUtilities Severomoravske Vodovody a Kanalizace Ostrava AS engages in the production and supply of drinking water. It also deals with the discharge and treatment of wastewater. The company was founded on April 30, 1992 and is headquartered in Ostrava, Czech Republic. | Utilities |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Tomas Navratil